Delivery Order SPE2DB22D9316-SPE2DB22FYM51

This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VELCADE 3.5 MG VIALS, a pharmaceutical product, with a ceiling value of $10,919.30. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 23, 2025. The contract was awarded on April 2, 2025 and does not have a set-aside designation,...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VELCADE 3.5 MG VIALS, with a ceiling value of $27,298.25 and a period of performance ending on July 23, 2025. The contract is not set-aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,438.60 firm fixed-price contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. The contract is not associated with a set-aside program and is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery...

This federal contract award is for the delivery of VELCADE 3.5 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $4,341.32. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,868.60 contract is for the delivery of VELCADE 3.5 MG VIALS, a specialized oncology medication, with a period of performance through August 7, 2023. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a...

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at eleven thousand four hundred thirty-four dollars and thirty cents ($11,434.30) to DMS Pharmaceutical Group Incorporated. The order is for four hundred fifty-six thousand two hundred thirty-five (456,235) vials of the pharmaceutical Velcade at three and a half (3.5) milligrams per vial. Performance will take place at DMS Pharmaceutical's facility...

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,286.86 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562330077 VELCADE 3.5 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from September 15, 2023 through October 6, 2023. No subcontractors or set aside designations were identified. This delivery order was likely placed against DLA's Pharmaceutical Prime Vendor contract to...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Velcade 3.5 mg vials. The contract has a potential value of $23,314.40 and a completion date of March 14, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of brand and generic prescription and over-the-counter drug...

The Defense Logistics Agency Medical Supply Chain awarded a $27,298.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for 3.5 mg vials of Velcade, a chemotherapy medication used in cancer treatment. Issued on September 15, 2025, with an ultimate completion date of October 6, 2025, this non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 3.5 mg vials of the pharmaceutical product VELCADE with a potential value of $2,331.44. The delivery order has a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug...